advanced primary liver cancer
Conditions
Interventions
the test group:Oxaliplatin + S-1
Sponsors
Affiliated Cancer Hospital of Guangxi Medical University/Cancer Hospital of Guangxi Zhuang Autonomous Region
Eligibility
Sex/Gender
All
Age
18 Years to 70 Years
Inclusion criteria
Inclusion criteria: (1) Patients who were histologically or cytologically confirmed to have advanced primary liver cancer, (2) Patients aged 18 to 70 years; (3) ECOG PS (Eastern Cooperative Oncology Group Performance Status) = 2; (5) Patients with expected survival of at least 2 months; (6) Patients with peripheral blood parameters as follows: WBC = 1.5 × 109 / L , HB = 80 g / L, PLT = 75.0 × 1012 / L,Creatinine 1.5 x or less normal limit; (7)Child liver function classification: A - B (8) Patients who had provided informed consent; (9) The trial was approved by the local ethics committees in all participating institutions.
Exclusion criteria
Exclusion criteria: 1.Patients participate in other clinical research at the same time;2.Patients with allergies to oxaliplatin or S-1;3.The researchers determine the patient doesnt fit to participate in this study,such as:(1)Patients with serious heart andliver dysfunctions,(2)Double cancer(3)bleeding,cant control the diabetes andhypertension,active inflammation;4.Patients with mental disease;5.Pregnant andnursing women;6.Refused to appropriate precautions of reproductive age patients (including men)
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| the diameter of target focus; | — |
Countries
China
Contacts
Public ContactYong-qiang Li
Outcome results
None listed